Abstract:Background The pentose phosphate pathway (PPP) plays a crucial role in the material and energy metabolism in cancer cells. Targeting 6-phosphogluconate dehydrogenase (6PGD), the rate-limiting enzyme in the PPP metabolic process, to inhibit cellular metabolism is an effective anticancer strategy. In our previous study, we have preliminarily demonstrated that gambogic acid (GA) induced cancer cell death by inhibiting 6PGD and suppressing PPP at the cellular level. However, it is unclear whether GA could suppress cancer cell growth by inhibiting PPP pathway in mouse model. Purpose This study aimed to confirm that GA as a covalent inhibitor of 6PGD protein and to validate that GA suppresses cancer cell growth by inhibiting the PPP pathway in a mouse model. Methods Cell viability was detected by CCK-8 assays as well as flow cytometry. The protein targets of GA were identified using a chemical probe and activity-based protein profiling (ABPP) technology. The target validation was performed by in-gel fluorescence assay, the Cellular Thermal Shift Assay (CETSA). A lung cancer mouse model was constructed to test the anticancer activity of GA. RNA sequencing was performed to analyze the global effect of GA on gene expression. Results The chemical probe of GA exhibited high biological activity in vitro . 6PGD was identified as one of the binding proteins of GA by ABPP. Our findings revealed a direct interaction between GA and 6PGD. We also found that the anti-cancer activity of GA depended on reactive oxygen species (ROS), as evidenced by experiments on cells with 6PGD knocked down. More importantly, GA could effectively reduce the production of the two major metabolites of the PPP in lung tissue and inhibit cancer cell growth in the mouse model. Finally, RNA sequencing data suggested that GA treatment significantly regulated apoptosis and hypoxia-related physiological processes. Conclusion These results demonstrated that GA was a covalent inhibitor of 6PGD protein. GA effectively suppressed cancer cell growth by inhibiting the PPP pathway without causing significant side effects in the mouse model. Our study provides in vivo evidence that elucidates the anticancer mechanism of GA, which involves the inhibition of 6PGD and modulation of cellular metabolic processes.

Gambogic Acid Inhibits Gastric Cancer Cell Proliferation through Necroptosis

Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis.

Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells.

Gambogic Acid Induces GSDME Dependent Pyroptotic Signaling Pathway Via ROS/P53/Mitochondria/Caspase-3 in Ovarian Cancer Cells

Gambogic acid-induced autophagy in nonsmall cell lung cancer NCI-H441 cells through a reactive oxygen species pathway

Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model

Autophagy Inhibition Promotes Gambogic Acid-Induced Suppression Of Growth And Apoptosis In Glioblastoma Cells

Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study.

Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog.

Gambogic Acid Mediates Apoptosis As a P53 Inducer Through Down-Regulation of Mdm2 in Wild-Type P53-Expressing Cancer Cells

Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.

Gambogic acid induces apoptosis of lung cancer H1975 cells by activating JNK signaling pathway and upregulating ROS

Gambogic Acid Inhibits Invasion Of Osteosarcoma Via Upregulation Of Timp-1

Anti-Invasive Effect Of Gambogic Acid In Mda-Mb-231 Human Breast Carcinoma Cells

Gambogenic acid induction of apoptosis in a breast cancer cell line.

Gambogenic acid induces apoptosis via upregulation of Noxa in oral squamous cell carcinoma

Gambogic acid impairs tumor angiogenesis by targeting YAP/STAT3 signaling axis.

Gambogenic acid inhibits proliferation and ferroptosis by targeting the miR‐1291/FOXA2 and AMPKα/SLC7A11/GPX4 axis in colorectal cancer

Ginkgolic Acid Suppresses the Development of Pancreatic Cancer by Inhibiting Pathways Driving Lipogenesis.

Blocking Autophagy Enhances the Apoptotic Effect of 18Β-Glycyrrhetinic Acid on Human Sarcoma Cells Via Endoplasmic Reticulum Stress and JNK Activation

Critical Role of Mir‐26a‐5p/wnt5a Signaling in Gambogic Acid‐induced Inhibition of Gastric Cancer